Acadia Pharmaceuticals | Spese Operative

Prezzo Delle Azioni
22.83
Cambio Giornaliero
0.80 3.63%
Mensile
-13.16%
Annuale
15.65%
Q1 Previsione
21.35




Spese Operative Cambiamento Data
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
ALKERMES USD 1.73B 1.44B 2025-09
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Cara Therapeutics USD 4.96M 2.38M 2025-03
Corcept Therapeutics USD 197.42M 29.66M 2025-09
Cytokinetics USD 168.69M 9.58M 2025-09
Eisai JPY 199.9B 16.22B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Incyte USD 1.12B 3.53B 2025-12
J&J USD 18.97B 2.38B 2025-12
Moderna USD 1.54B 259M 2025-12
Neurocrine Biosciences USD 577.6M 22M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Prothena USD 42.18M 14.25M 2025-09
PTC Therapeutics USD 207.52M 6.21M 2025-09
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vanda Pharmaceuticals USD 466M 20.33M 2025-09
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12


Acadia Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.